Latest Insider Transactions at Arcadia Biosciences, Inc. (RKDA)
This section provides a real-time view of insider transactions for Arcadia Biosciences, Inc. (RKDA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Arcadia Biosciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Arcadia Biosciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 01
2024
|
Mark Kawakami Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
700
+26.11%
|
$1,400
$2.06 P/Share
|
Aug 01
2024
|
Thomas J. Schaefer Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
700
+24.83%
|
$1,400
$2.06 P/Share
|
Feb 01
2024
|
Thomas J. Schaefer Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
700
+33.03%
|
$1,400
$2.06 P/Share
|
Aug 04
2023
|
Thomas J. Schaefer Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
649
+47.44%
|
$1,947
$3.67 P/Share
|
May 30
2023
|
Stanley Jacot Jr Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$20,000
$4.31 P/Share
|
Feb 01
2023
|
Thomas J. Schaefer Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
700
+20.0%
|
$0
$0.23 P/Share
|
Aug 01
2022
|
Pamela Haley Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
700
+12.09%
|
$0
$0.7 P/Share
|
Aug 03
2020
|
Pamela Haley Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
700
+20.97%
|
$2,100
$3.16 P/Share
|
Aug 03
2020
|
Randall Shultz Chief Technology Officer |
BUY
Open market or private purchase
|
Direct |
700
+5.11%
|
$2,100
$3.16 P/Share
|
Aug 03
2020
|
Matthew T Plavan Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
585
+3.93%
|
$1,755
$3.16 P/Share
|